Study to determine which stool test is best for colorectal cancer detection
Share

IMAGE: Navkiran Shokar, M.D., M.P.H., M.A., of Texas Tech University Health Sciences Center El Paso (TTUHSC El Paso) is part of a study to assess the accuracy of fecal immunochemical tests…. view more 

Credit: Tommie Morelos / TTUHSC El Paso

No one wants a colonoscopy. But there’s no getting around the lifesaving procedure — the gold standard for colon cancer detection.

With the development of the FIT test, or fecal immunochemical test, many breathed a sigh of relief. The noninvasive tool promises to accurately detect blood in the stool, often an early sign of cancer, allowing patients to skip the colonoscopy if test results are negative. What’s more, the sample can be collected in the privacy of one’s own home with no dietary or medical restrictions.

But just how accurate are these new FIT tests?

That’s what faculty at Texas Tech University Health Sciences Center El Paso (TTUHSC El Paso) and a team of scientists from across the U.S. hope to find out. The research consortium, led by Barcey Levy, M.D., Ph.D., at the University of Iowa, was recently awarded $4.5 million over five years as part of the Cancer MoonshotSM funded by the National Cancer Institute, National Institutes

read more...


Article originally posted at
www.eurekalert.org

Click here for the full story


CategoryAggregator News

© 2017 - LIFE EXTENSION ADVOCACY FOUNDATION
Privacy Policy / Terms Of Use

Powered by MMD